Skip to main content
Eutilex Co.,Ltd. logo

Eutilex Co.,Ltd. — Investor Relations & Filings

Ticker · 263050 ISIN · KR7263050007 KO Manufacturing
Filings indexed 410 across all filing types
Latest filing 2025-02-13 Earnings Release
Country KR South Korea
Listing KO 263050

About Eutilex Co.,Ltd.

https://www.eutilex.com/en/

Eutilex Co., Ltd. is a biotechnology company focused on the research and development of immunotherapeutics for cancers and autoimmune diseases. The company's core approach involves selecting targets that enhance or suppress human immune responses. Its pipeline is centered on three primary technology platforms: T-cell therapy, antibody therapy, and CAR-T cell therapy. Key development programs include adoptive T-cell therapies, such as those based on 4-1BB cytotoxic T lymphocytes (CTL), and various immunomodulatory antibody therapeutics designed to treat a range of incurable diseases.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Eutilex regarding a significant change (over 30%) in revenue or profit structure. It provides key financial highlights (revenue, operating profit, net income) for the current and previous fiscal years, along with the reasons for the change and the board resolution date. This is a standard preliminary financial disclosure required by the Korea Exchange (KRX) for listed companies, which fits the definition of an Earnings Release (ER) as it provides initial highlights of financial performance before the full audit is finalized. FY 2024
2025-02-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the shareholder register in preparation for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of a corporate action related to shareholder rights. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2024-12-13 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Eutilex' (주식회사 유틸렉스) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business operations, management discussions, and capital structure data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Byoung S. Kwon) of Eutilex. This type of filing is a standard regulatory requirement in South Korea for reporting insider transactions or changes in share ownership by directors and major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2024-11-04 Korean
단기차입금증가결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement from Eutilex regarding a decision to increase short-term borrowings. It details the loan amount, the purpose (operating funds), and the board resolution date. This falls under financing activities and capital structure changes, which aligns with the 'Capital/Financing Update' category.
2024-10-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of share issues or capital changes.
2024-10-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.